4//SEC Filing
Miller Joseph M 4
Accession 0001600620-26-000003
CIK 0001600620other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:11 PM ET
Size
6.7 KB
Accession
0001600620-26-000003
Insider Transaction Report
Form 4
Miller Joseph M
Chief Financial Officer
Transactions
- Award
Common Stock
2026-01-02+49,038→ 626,399 total - Tax Payment
Common Stock
2026-01-02$15.95/sh−40,161$640,568→ 589,127 total
Footnotes (3)
- [F1]Represents the number of shares earned upon certification of performance for a performance award payable solely in common shares of the Issuer that vest in two (2) equal annual installments on December 31, 2025 and December 31, 2026.
- [F2]Represents shares withheld to satisfy tax withholding obligations upon the vesting of performance awards.
- [F3]Includes common shares acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 1,721 common shares were acquired on May 30, 2025 and 1,168 common shares were acquired on November 28, 2025.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0001746372
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:11 PM ET
- Size
- 6.7 KB